Manager, FP&A
Full-timeMANAGEROpeningsOncologyAntibodies
$120K - $155K/yr(from employer)
Description
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
We are seeking a Senior FP&A Analyst will play a critical role in supporting corporate and program level planning, budgeting, and forecasting. This individual will partner closely with R&D, Program Management, Clinical, Tech Ops, and G&A teams to deliver high quality financial insights, support decision making, and ensure disciplined financial management in a dynamic, science-driven environment.
This role is ideal for someone who thrives in high growth biotech, can balance strategic thinking with hands on execution, and is excited to build scalable FP&A processes.
Crescent Biopharma
PHARMACEUTICAL
Oncology Therapies
LocationWALTHAM, MA
Open Jobs12
Oncology
View Company ProfilePipeline
Self Help PlusN/A
A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and MucusN/A
Motivational interviewN/A
InfectedN/A
Folic acidN/A